Dr. Daniel A. Traylor, PhD
Co-Founder, Lead Researcher
My lifelong quest is to pinpoint the optimal formula intake to peak muscle performance and wellness. With ongoing studies, my team of dedicated PhDs is driving nutrient innovations to continue developing products to maximize muscle protein synthesis. As a former athlete and professional strength and conditioning coach, I am intrigued by the prospect of continuing cutting-edge research to promote MPS and learning through science.
Our story
LEUVATE™ began with one goal: to make clinically proven muscle support accessible through precision amino acid science. Backed by over fifteen years of human clinical trials, we’ve transformed peer-reviewed research into micro-dose formulas that help people build, preserve, and recover lean mass, without excess calories, fillers, or hype. Our journey is grounded in trust, transparency, and a relentless focus on muscle health across all life stages.
Researching Since
Completed & Active Clinical Trials
5+
Our values
At LEUVATE™, science comes first. Every claim we make is backed by published research, not marketing spin. We lead with transparency, no proprietary blends, no hidden ingredients, no shortcuts. From GMP-certified manufacturing to third-party testing, we deliver uncompromising quality. Our mission is to support every customer with solutions that are evidence-based, accessible, and designed to advance real muscle health.
Scientists, PhDs, and Investigation Team
Internal Medicine specialist and board-certified physician with extensive clinical research experience. Associate Professor at UNC School of Medicine and lead researcher for Novo Nordisk, completing 12 human clinical trials. Owner of Whiteville Medical Associates, P.A.
Focuses on exercise recovery, performance optimization, and amino acid dosing strategies. Co-author on LEUVATE™’s plasma leucine studies and functional outcome trials.
Specialist in amino acid kinetics and metabolic adaptation. Dr. Nunes contributes to Leuvate’s mechanistic research on mTOR activation and EAA utilization across age groups.